ATE88640T1 - Verwendung des tumor-nekrose-faktors als adjuvans der immunantwort. - Google Patents

Verwendung des tumor-nekrose-faktors als adjuvans der immunantwort.

Info

Publication number
ATE88640T1
ATE88640T1 AT88118155T AT88118155T ATE88640T1 AT E88640 T1 ATE88640 T1 AT E88640T1 AT 88118155 T AT88118155 T AT 88118155T AT 88118155 T AT88118155 T AT 88118155T AT E88640 T1 ATE88640 T1 AT E88640T1
Authority
AT
Austria
Prior art keywords
immune response
necrosis factor
adjuvant
tumor necrosis
onf
Prior art date
Application number
AT88118155T
Other languages
English (en)
Inventor
Paolo Ghiara
Luigi Villa
Luciano Nencioni
Aldo Tagliabue
Diana Boraschi
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Application granted granted Critical
Publication of ATE88640T1 publication Critical patent/ATE88640T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88118155T 1987-11-02 1988-10-31 Verwendung des tumor-nekrose-faktors als adjuvans der immunantwort. ATE88640T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8722486A IT1223339B (it) 1987-11-02 1987-11-02 Uso del fattore di necrosi tumorale come adiuvante della risposta immunitaria

Publications (1)

Publication Number Publication Date
ATE88640T1 true ATE88640T1 (de) 1993-05-15

Family

ID=11196921

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88118155T ATE88640T1 (de) 1987-11-02 1988-10-31 Verwendung des tumor-nekrose-faktors als adjuvans der immunantwort.

Country Status (7)

Country Link
EP (1) EP0315110B1 (de)
JP (1) JPH01221322A (de)
AT (1) ATE88640T1 (de)
DE (1) DE3880625T2 (de)
ES (1) ES2054768T3 (de)
GR (1) GR3007746T3 (de)
IT (1) IT1223339B (de)

Also Published As

Publication number Publication date
EP0315110A3 (en) 1989-08-09
EP0315110B1 (de) 1993-04-28
DE3880625D1 (de) 1993-06-03
DE3880625T2 (de) 1993-08-12
JPH01221322A (ja) 1989-09-04
IT1223339B (it) 1990-09-19
GR3007746T3 (de) 1993-08-31
ES2054768T3 (es) 1994-08-16
EP0315110A2 (de) 1989-05-10
IT8722486A0 (it) 1987-11-02

Similar Documents

Publication Publication Date Title
ATE229978T1 (de) Helicobacter proteine und impstoffe
NO892251D0 (no) Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker.
EP0701571A1 (de) Antikoerperfragmente in therapie
DE3679708D1 (de) Verfahren zur verleihung von immuntoleranz gegen ein spezifisches antigen.
EP0673255A4 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon.
ATE261314T1 (de) P53 impfstoff
FI920912A0 (fi) Varjoainevalmisteet
EP0202642A3 (de) Verfahren zur in vitro-Immunisierung von Humanmilzzellen gegen tumorassoziierte Antigene
DE3880625D1 (de) Verwendung des tumor-nekrose-faktors als adjuvans der immunantwort.
DE3884672D1 (de) Ein synthetisches Nonapeptid zur Verwendung als Adjuvant.
WO1991017187A3 (en) A 35kd tumor associated protein antigen: uses and methods of detection
IT1218249B (it) Centro di montaggio di mobili e simili
NO881942D0 (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
AU532186B2 (en) Herpes virus vaccine
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
EP0320034A3 (de) Synthetische Peptide, die immunologische Aktivität zeigen, benutzbar, um eine Impfung gegen Malaria vorzubereiten
AU2715288A (en) Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein
AU2568692A (en) Porcine adipocyte antigens and their use in the immunological control of fat
NO900121L (no) Probursin.
IT8723266A0 (it) Procedimento per la fabbricazione di tappeti e simili.
OA08626A (en) Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections.
Strelkov Regulation of muscle protein turnover in the tumour-bearing host
Predy Characterization of novel antigens, detected using monoclonal antibodies raised against tissue from the central nervous system of multiple sclerosis patients
ATE159758T1 (de) Azelluläre impfstoffe
NO914094L (no) Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties